Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7802777.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diagnostic tests on saliva have advantages compared with those on serum. In 119 consecutive dyspeptic patients referred for endoscopy we developed and validated an enzyme-linked immunosorbent assay to detect salivary immunoglobulins to Helicobacter pylori. Salivary IgG distinguished positive and negative cases (p < 0.0001), but salivary IgA did not. The optimum performance of salivary IgG (85%) was similar to that of serum IgG (90%) and better than that of salivary IgA. Using our assay and a history of regular use of non-steroidal anti-inflammatories in screening patients under 45 years, we detected all peptic ulcers while saving 39% of endoscopies.
Medical subject headings
- Antibodies, Bacterial
- Dyspepsia
- Endoscopy, Gastrointestinal
- Helicobacter pylori
- Saliva